STENOCARE: New video regarding the profitable Year-End Report 2019 and the road ahead
In todays video, the CEO of STENOCARE – Thomas Skovlund Schnegelsberg – shares an update on the top-5 hightlights for STENOCARE:
- Profitable for 2019 – as one of few in the European medical cannabis industry
- Close to end of pause in sales
- Recognized as a European leader by leading industry analysts
- Planning to expand into more European markets
- Looking for investment and acquisition opportunities in the industry
The video is available on the STENOCARE website:
https://stenocare.com/investor-relations/#news
For additional information regarding STENOCARE, please contact:
Thomas Skovlund Schnegelsberg, CEO
Phone: +45 31770060
E-mail: presse@stenocare.com
About STENOCARE A/S
STENOCARE A/S was founded in 2017 with the purpose of being an active participant in the Danish medical cannabis pilot program. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. The company was the first to supply medical cannabis oil products that complies with the strict Danish regulatory requirements. STENOCARE is building a state-of-the-art production facility for the cultivation and production of medical cannabis at the company’s premises in Jutland, Denmark.